Constipation
Pipeline by Development Stage
Competitive Landscape
26 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 8,155 patients across 50 trials
Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
Trial of Alvimopan in Major Spine Surgery
Study to Gather Information on the Acceptability of a New Flavor System With Increasing Levels of 2, 4, 6 g or Higher of Mannitol for PEG 3350 in Subjects Having Infrequent Bowel Movements.
A Preference Study Comparing Kristalose® and Liquid Lactulose
Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit
Comparison of PEG Solutions With and Without Electrolytes in the Treatment of Constipation
Study Comparing PEG 3350 Laxative to Placebo in the Treatment of Occasional Constipation (Study CL2007-12)(P08216)
A Study to Compare the Effect of Transipeg 2.95 g or Forlax Junior 4 g in Children With Constipation
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury
Study of Long-term Use of Forlax® in Elderly Patients With Chronic Constipation
The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit
Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers
Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005)
Lubiprostone for Children With Constipation
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
Comparator Study of PEG 3350 Versus Prucalopride in Females With Chronic Constipation
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
Evaluating the Effectiveness of LACTOFOS in Constipated Patients
Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation
Constipation Associated With Irritable Bowel Syndrome (IBS-C)
Sodium Picosulphate vs. Placebo in Functional Constipation
Dulcolax vs Placebo in Functional Constipation
An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation
Efficacy and Tolerability of Bisacodyl Sugar Coated Tablets, Simeticone Chewing Tablets and Their Combination in Constipation and Bloatedness
Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain
Naloxegol in Cancer Opioid-Induced Constipation
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003)
Dose-Finding Trial of Polyethylene Glycol 3350 Laxative Plus Electrolytes for the Treatment of Constipation (Protocol P07515)
Investigation of KLYX in Patients With Constipation
Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain
Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain
Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation
TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects
Intestinal Microecology in Chronic Constipation
Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-hour IV of MOA-728 in Stable Methadone Subjects
A Novel Iron Supplement for Athletes: Phase I
Tolerability and Functional Assessment of a Novel Children's Synbiotic
Influence of Body Position on the Defecation Model During Anorectal Manometry.
Comparison of Anorectal Manometry and 3D Manometry in Diagnosis of Functional Disorders in Children
Effectiveness and Safety of Sacral Neuromodulation in Patients With Idiopathic Slow-transit Constipation
Effectiveness and Cost-effectiveness of Sacral Neuromodulation in Patients With Idiopathic Slow-transit Constipation
MRI and Microbiota Analysis in Constipation
Lubiprostone as a Treatment for Constipation in Parkinson's Disease
Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis
The Bowel Research Collaborative Data Tracking System Implementation Study
Efficacy of Lubiprostone in Combination With Standard PEG Preparation
Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation
Predictors of Constipation in Healthy Children
Related Jobs
Senior Manager, FP&A
Head of Drug Product Development
Senior Director, Investor Relations and Corporate Communications
Clinical Operations Lead, Development Operations
Director, Global Regulatory Affairs (GRA) - CMC
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.